Concepedia
Statistics
Publications
9
Citations
226
H-Index
Active since
2006
Affiliations
The Ohio State University(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Center for Innovation
Shankaran Kothandaraman is an author at The Ohio State University specializing in pharmacology, molecular imaging, and medicine.
Publications per year
2006–2020
Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT
John Christoforidis, Michelle M. Williams, Shankaran Kothandaraman et al. · Current Eye Research · 2012 · 60 citations
Medicine, Nuclear Medicine, Pharmacokinetics +13
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties
Gabor Butora, Gregori J. Morriello, Shankaran Kothandaraman et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 38 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
Design, synthesis, and structure–activity relationship of novel CCR2 antagonists
Shankaran Kothandaraman, Karla L. Donnely, Gabor Butora et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 25 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
A High-Affinity Near-Infrared Fluorescent Probe to Target Bombesin Receptors
Ajay Shrivastava, Haiming Ding, Shankaran Kothandaraman et al. · Molecular Imaging and Biology · 2014 · 21 citations · Full text
Pharmacy, Molecular Pharmaceutics, Pharmacology +13
Site Specific Discrete PEGylation of <sup>124</sup>I-Labeled mCC49 Fab′ Fragments Improves Tumor MicroPET/CT Imaging in Mice
Haiming Ding, Michelle M. Carlton, Stephen P. Povoski et al. · Bioconjugate Chemistry · 2013 · 20 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 9